nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC5—Rifampicin—leprosy	0.242	0.279	CbGbCtD
Sildenafil—CYP1A1—Thalidomide—leprosy	0.0596	0.0687	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0462	0.0532	CbGbCtD
Sildenafil—CYP3A7—Rifampicin—leprosy	0.0462	0.0532	CbGbCtD
Sildenafil—CYP2E1—Thalidomide—leprosy	0.0461	0.0531	CbGbCtD
Sildenafil—CYP2E1—Rifampicin—leprosy	0.0446	0.0514	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0381	0.0439	CbGbCtD
Sildenafil—CYP3A7—Dapsone—leprosy	0.0381	0.0439	CbGbCtD
Sildenafil—CYP2E1—Dapsone—leprosy	0.0368	0.0424	CbGbCtD
Sildenafil—CYP3A5—Thalidomide—leprosy	0.0358	0.0412	CbGbCtD
Sildenafil—CYP3A5—Rifampicin—leprosy	0.0347	0.0399	CbGbCtD
Sildenafil—CYP2C19—Thalidomide—leprosy	0.0289	0.0333	CbGbCtD
Sildenafil—CYP3A5—Dapsone—leprosy	0.0286	0.033	CbGbCtD
Sildenafil—CYP2C19—Rifampicin—leprosy	0.028	0.0322	CbGbCtD
Sildenafil—CYP2C9—Thalidomide—leprosy	0.024	0.0276	CbGbCtD
Sildenafil—CYP2C9—Rifampicin—leprosy	0.0232	0.0268	CbGbCtD
Sildenafil—CYP2C19—Dapsone—leprosy	0.0231	0.0266	CbGbCtD
Sildenafil—CYP2C9—Dapsone—leprosy	0.0192	0.0221	CbGbCtD
Sildenafil—CYP3A4—Rifampicin—leprosy	0.0135	0.0156	CbGbCtD
Sildenafil—CYP3A4—Dapsone—leprosy	0.0112	0.0129	CbGbCtD
Sildenafil—Anxiety depression—Thalidomide—leprosy	0.00483	0.0443	CcSEcCtD
Sildenafil—PDE6C—eye—leprosy	0.00416	0.183	CbGeAlD
Sildenafil—Bronchopneumonia—Thalidomide—leprosy	0.00363	0.0333	CcSEcCtD
Sildenafil—Lacrimal structural disorder—Thalidomide—leprosy	0.0027	0.0247	CcSEcCtD
Sildenafil—PDE6H—eye—leprosy	0.00245	0.108	CbGeAlD
Sildenafil—PDE6G—eye—leprosy	0.00236	0.104	CbGeAlD
Sildenafil—Lacrimal disorder—Thalidomide—leprosy	0.00177	0.0162	CcSEcCtD
Sildenafil—PDE5A—blood vessel—leprosy	0.00175	0.0772	CbGeAlD
Sildenafil—Hyporeflexia—Thalidomide—leprosy	0.00174	0.016	CcSEcCtD
Sildenafil—Hernia—Thalidomide—leprosy	0.00169	0.0155	CcSEcCtD
Sildenafil—Transient ischaemic attack—Thalidomide—leprosy	0.00157	0.0144	CcSEcCtD
Sildenafil—Sexual dysfunction—Thalidomide—leprosy	0.00141	0.013	CcSEcCtD
Sildenafil—PDE6H—nervous system—leprosy	0.00132	0.0581	CbGeAlD
Sildenafil—PDE6G—testis—leprosy	0.00129	0.057	CbGeAlD
Sildenafil—Myasthenia—Thalidomide—leprosy	0.00126	0.0116	CcSEcCtD
Sildenafil—Tooth disorder—Thalidomide—leprosy	0.00122	0.0112	CcSEcCtD
Sildenafil—Nail disorder—Thalidomide—leprosy	0.00122	0.0112	CcSEcCtD
Sildenafil—Burning sensation—Thalidomide—leprosy	0.00114	0.0105	CcSEcCtD
Sildenafil—Neuralgia—Thalidomide—leprosy	0.00114	0.0105	CcSEcCtD
Sildenafil—CYP1A1—skin epidermis—leprosy	0.00111	0.049	CbGeAlD
Sildenafil—Hyperlipidaemia—Thalidomide—leprosy	0.0011	0.0101	CcSEcCtD
Sildenafil—Skin ulcer—Thalidomide—leprosy	0.00102	0.00933	CcSEcCtD
Sildenafil—Hyperaesthesia—Thalidomide—leprosy	0.00101	0.00926	CcSEcCtD
Sildenafil—Nasopharyngitis—Dapsone—leprosy	0.001	0.00921	CcSEcCtD
Sildenafil—Muscular weakness—Dapsone—leprosy	0.000991	0.00909	CcSEcCtD
Sildenafil—Myocardial ischaemia—Thalidomide—leprosy	0.000986	0.00904	CcSEcCtD
Sildenafil—Influenza—Dapsone—leprosy	0.000971	0.0089	CcSEcCtD
Sildenafil—Endocrine disorder—Thalidomide—leprosy	0.000956	0.00876	CcSEcCtD
Sildenafil—PDE5A—eye—leprosy	0.000933	0.0411	CbGeAlD
Sildenafil—Vasodilation—Thalidomide—leprosy	0.000902	0.00827	CcSEcCtD
Sildenafil—Vasodilation procedure—Thalidomide—leprosy	0.000902	0.00827	CcSEcCtD
Sildenafil—Accidental injury—Thalidomide—leprosy	0.000896	0.00821	CcSEcCtD
Sildenafil—Photosensitivity reaction—Dapsone—leprosy	0.000886	0.00813	CcSEcCtD
Sildenafil—Bone disorder—Thalidomide—leprosy	0.000877	0.00804	CcSEcCtD
Sildenafil—Cellulitis—Thalidomide—leprosy	0.000871	0.00799	CcSEcCtD
Sildenafil—Arthropathy—Thalidomide—leprosy	0.000871	0.00799	CcSEcCtD
Sildenafil—Herpes simplex—Thalidomide—leprosy	0.00086	0.00788	CcSEcCtD
Sildenafil—Hyperuricaemia—Thalidomide—leprosy	0.000854	0.00783	CcSEcCtD
Sildenafil—Neuropathy peripheral—Dapsone—leprosy	0.000849	0.00778	CcSEcCtD
Sildenafil—Hearing impaired—Thalidomide—leprosy	0.000832	0.00763	CcSEcCtD
Sildenafil—Bone pain—Thalidomide—leprosy	0.000827	0.00758	CcSEcCtD
Sildenafil—Atrioventricular block—Thalidomide—leprosy	0.000817	0.00749	CcSEcCtD
Sildenafil—Sinusitis—Dapsone—leprosy	0.000812	0.00745	CcSEcCtD
Sildenafil—Blood uric acid increased—Thalidomide—leprosy	0.000807	0.0074	CcSEcCtD
Sildenafil—Eructation—Thalidomide—leprosy	0.000778	0.00714	CcSEcCtD
Sildenafil—Pharyngitis—Dapsone—leprosy	0.000771	0.00707	CcSEcCtD
Sildenafil—Colitis—Thalidomide—leprosy	0.000761	0.00698	CcSEcCtD
Sildenafil—Neuropathy—Thalidomide—leprosy	0.000744	0.00682	CcSEcCtD
Sildenafil—Dry eye—Thalidomide—leprosy	0.000732	0.00671	CcSEcCtD
Sildenafil—Tinnitus—Dapsone—leprosy	0.000725	0.00664	CcSEcCtD
Sildenafil—Oesophagitis—Thalidomide—leprosy	0.000724	0.00664	CcSEcCtD
Sildenafil—Gynaecomastia—Thalidomide—leprosy	0.000709	0.0065	CcSEcCtD
Sildenafil—Hypertonia—Thalidomide—leprosy	0.000695	0.00637	CcSEcCtD
Sildenafil—Erythema—Dapsone—leprosy	0.000677	0.0062	CcSEcCtD
Sildenafil—Diabetes mellitus—Thalidomide—leprosy	0.000661	0.00606	CcSEcCtD
Sildenafil—Gastroenteritis—Thalidomide—leprosy	0.000649	0.00595	CcSEcCtD
Sildenafil—Deafness—Thalidomide—leprosy	0.000643	0.0059	CcSEcCtD
Sildenafil—Vision blurred—Dapsone—leprosy	0.000638	0.00585	CcSEcCtD
Sildenafil—Eye pain—Thalidomide—leprosy	0.000637	0.00584	CcSEcCtD
Sildenafil—Injury—Thalidomide—leprosy	0.000626	0.00574	CcSEcCtD
Sildenafil—PDE5A—tendon—leprosy	0.000618	0.0272	CbGeAlD
Sildenafil—Increased appetite—Thalidomide—leprosy	0.000612	0.00561	CcSEcCtD
Sildenafil—Dermatitis exfoliative—Thalidomide—leprosy	0.00061	0.00559	CcSEcCtD
Sildenafil—Vertigo—Dapsone—leprosy	0.000608	0.00557	CcSEcCtD
Sildenafil—Visual disturbance—Thalidomide—leprosy	0.000607	0.00556	CcSEcCtD
Sildenafil—Atrial fibrillation—Thalidomide—leprosy	0.000607	0.00556	CcSEcCtD
Sildenafil—Arthritis—Thalidomide—leprosy	0.000592	0.00543	CcSEcCtD
Sildenafil—Cough—Dapsone—leprosy	0.00059	0.00541	CcSEcCtD
Sildenafil—Cardiac failure—Thalidomide—leprosy	0.000589	0.0054	CcSEcCtD
Sildenafil—Hypoglycaemia—Thalidomide—leprosy	0.000589	0.0054	CcSEcCtD
Sildenafil—Cerebrovascular accident—Thalidomide—leprosy	0.000587	0.00538	CcSEcCtD
Sildenafil—Pain in extremity—Thalidomide—leprosy	0.000575	0.00527	CcSEcCtD
Sildenafil—Osteoarthritis—Thalidomide—leprosy	0.000575	0.00527	CcSEcCtD
Sildenafil—Diplopia—Thalidomide—leprosy	0.000575	0.00527	CcSEcCtD
Sildenafil—Migraine—Thalidomide—leprosy	0.000566	0.00519	CcSEcCtD
Sildenafil—ABCC5—tendon—leprosy	0.000565	0.0249	CbGeAlD
Sildenafil—ADORA2A—testis—leprosy	0.000562	0.0247	CbGeAlD
Sildenafil—Face oedema—Thalidomide—leprosy	0.000555	0.00509	CcSEcCtD
Sildenafil—ADORA2A—nervous system—leprosy	0.000551	0.0243	CbGeAlD
Sildenafil—Cardiac arrest—Thalidomide—leprosy	0.000547	0.00501	CcSEcCtD
Sildenafil—Ataxia—Thalidomide—leprosy	0.000541	0.00496	CcSEcCtD
Sildenafil—Tachycardia—Dapsone—leprosy	0.000539	0.00494	CcSEcCtD
Sildenafil—Liver function test abnormal—Thalidomide—leprosy	0.000531	0.00487	CcSEcCtD
Sildenafil—Orthostatic hypotension—Thalidomide—leprosy	0.000525	0.00482	CcSEcCtD
Sildenafil—Hypokalaemia—Thalidomide—leprosy	0.000523	0.0048	CcSEcCtD
Sildenafil—Breast disorder—Thalidomide—leprosy	0.00052	0.00477	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000518	0.00475	CcSEcCtD
Sildenafil—PDE5A—testis—leprosy	0.000511	0.0225	CbGeAlD
Sildenafil—Muscular weakness—Thalidomide—leprosy	0.000507	0.00465	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Thalidomide—leprosy	0.000507	0.00465	CcSEcCtD
Sildenafil—PDE5A—nervous system—leprosy	0.000502	0.0221	CbGeAlD
Sildenafil—Abdominal distension—Thalidomide—leprosy	0.0005	0.00459	CcSEcCtD
Sildenafil—Insomnia—Dapsone—leprosy	0.000499	0.00458	CcSEcCtD
Sildenafil—Influenza—Thalidomide—leprosy	0.000497	0.00456	CcSEcCtD
Sildenafil—Dysphagia—Thalidomide—leprosy	0.000497	0.00456	CcSEcCtD
Sildenafil—Angina pectoris—Thalidomide—leprosy	0.000484	0.00444	CcSEcCtD
Sildenafil—Bronchitis—Thalidomide—leprosy	0.000478	0.00438	CcSEcCtD
Sildenafil—ABCC10—tendon—leprosy	0.000472	0.0208	CbGeAlD
Sildenafil—ABCC5—testis—leprosy	0.000468	0.0206	CbGeAlD
Sildenafil—Upper respiratory tract infection—Thalidomide—leprosy	0.000462	0.00424	CcSEcCtD
Sildenafil—Pollakiuria—Thalidomide—leprosy	0.000459	0.00421	CcSEcCtD
Sildenafil—Erectile dysfunction—Thalidomide—leprosy	0.000458	0.0042	CcSEcCtD
Sildenafil—Photosensitivity reaction—Thalidomide—leprosy	0.000454	0.00416	CcSEcCtD
Sildenafil—Weight increased—Thalidomide—leprosy	0.000452	0.00415	CcSEcCtD
Sildenafil—Gastrointestinal pain—Dapsone—leprosy	0.000452	0.00414	CcSEcCtD
Sildenafil—Hyperglycaemia—Thalidomide—leprosy	0.000448	0.00411	CcSEcCtD
Sildenafil—Pneumonia—Thalidomide—leprosy	0.000446	0.00409	CcSEcCtD
Sildenafil—Infestation NOS—Thalidomide—leprosy	0.000443	0.00406	CcSEcCtD
Sildenafil—Infestation—Thalidomide—leprosy	0.000443	0.00406	CcSEcCtD
Sildenafil—Depression—Thalidomide—leprosy	0.000442	0.00405	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000439	0.00403	CcSEcCtD
Sildenafil—Acute coronary syndrome—Thalidomide—leprosy	0.000437	0.00401	CcSEcCtD
Sildenafil—Abdominal pain—Dapsone—leprosy	0.000437	0.004	CcSEcCtD
Sildenafil—Body temperature increased—Dapsone—leprosy	0.000437	0.004	CcSEcCtD
Sildenafil—Renal failure—Thalidomide—leprosy	0.000436	0.00399	CcSEcCtD
Sildenafil—Myocardial infarction—Thalidomide—leprosy	0.000434	0.00398	CcSEcCtD
Sildenafil—Neuropathy peripheral—Thalidomide—leprosy	0.000434	0.00398	CcSEcCtD
Sildenafil—Stomatitis—Thalidomide—leprosy	0.000432	0.00396	CcSEcCtD
Sildenafil—Conjunctivitis—Thalidomide—leprosy	0.000431	0.00395	CcSEcCtD
Sildenafil—Sweating—Thalidomide—leprosy	0.000425	0.0039	CcSEcCtD
Sildenafil—Haematuria—Thalidomide—leprosy	0.000423	0.00387	CcSEcCtD
Sildenafil—Epistaxis—Thalidomide—leprosy	0.000418	0.00383	CcSEcCtD
Sildenafil—Sinusitis—Thalidomide—leprosy	0.000416	0.00381	CcSEcCtD
Sildenafil—Rhinitis—Thalidomide—leprosy	0.000399	0.00366	CcSEcCtD
Sildenafil—Hypoaesthesia—Thalidomide—leprosy	0.000396	0.00363	CcSEcCtD
Sildenafil—Pharyngitis—Thalidomide—leprosy	0.000395	0.00362	CcSEcCtD
Sildenafil—Urinary tract disorder—Thalidomide—leprosy	0.000393	0.0036	CcSEcCtD
Sildenafil—Oedema peripheral—Thalidomide—leprosy	0.000392	0.00359	CcSEcCtD
Sildenafil—ABCC4—tendon—leprosy	0.000392	0.0172	CbGeAlD
Sildenafil—ABCC10—testis—leprosy	0.000391	0.0172	CbGeAlD
Sildenafil—Urethral disorder—Thalidomide—leprosy	0.00039	0.00358	CcSEcCtD
Sildenafil—Visual impairment—Thalidomide—leprosy	0.000383	0.00352	CcSEcCtD
Sildenafil—Erythema multiforme—Thalidomide—leprosy	0.000376	0.00345	CcSEcCtD
Sildenafil—Eye disorder—Thalidomide—leprosy	0.000372	0.00341	CcSEcCtD
Sildenafil—Tinnitus—Thalidomide—leprosy	0.000371	0.0034	CcSEcCtD
Sildenafil—Cardiac disorder—Thalidomide—leprosy	0.000369	0.00339	CcSEcCtD
Sildenafil—Angiopathy—Thalidomide—leprosy	0.000361	0.00331	CcSEcCtD
Sildenafil—Immune system disorder—Thalidomide—leprosy	0.000359	0.0033	CcSEcCtD
Sildenafil—Mediastinal disorder—Thalidomide—leprosy	0.000359	0.00329	CcSEcCtD
Sildenafil—Chills—Thalidomide—leprosy	0.000357	0.00327	CcSEcCtD
Sildenafil—Arrhythmia—Thalidomide—leprosy	0.000355	0.00326	CcSEcCtD
Sildenafil—Alopecia—Thalidomide—leprosy	0.000352	0.00322	CcSEcCtD
Sildenafil—Vomiting—Dapsone—leprosy	0.000351	0.00322	CcSEcCtD
Sildenafil—Mental disorder—Thalidomide—leprosy	0.000349	0.0032	CcSEcCtD
Sildenafil—Malnutrition—Thalidomide—leprosy	0.000346	0.00318	CcSEcCtD
Sildenafil—Headache—Dapsone—leprosy	0.000346	0.00317	CcSEcCtD
Sildenafil—CYP1A1—skin of body—leprosy	0.000345	0.0152	CbGeAlD
Sildenafil—Flatulence—Thalidomide—leprosy	0.000341	0.00313	CcSEcCtD
Sildenafil—Tension—Thalidomide—leprosy	0.00034	0.00312	CcSEcCtD
Sildenafil—Nervousness—Thalidomide—leprosy	0.000336	0.00308	CcSEcCtD
Sildenafil—Back pain—Thalidomide—leprosy	0.000335	0.00307	CcSEcCtD
Sildenafil—Nausea—Dapsone—leprosy	0.000328	0.00301	CcSEcCtD
Sildenafil—Vision blurred—Thalidomide—leprosy	0.000326	0.00299	CcSEcCtD
Sildenafil—Tremor—Thalidomide—leprosy	0.000325	0.00298	CcSEcCtD
Sildenafil—ABCC4—testis—leprosy	0.000324	0.0143	CbGeAlD
Sildenafil—Ill-defined disorder—Thalidomide—leprosy	0.000321	0.00295	CcSEcCtD
Sildenafil—Anaemia—Thalidomide—leprosy	0.00032	0.00294	CcSEcCtD
Sildenafil—Agitation—Thalidomide—leprosy	0.000318	0.00292	CcSEcCtD
Sildenafil—ABCC4—nervous system—leprosy	0.000318	0.014	CbGeAlD
Sildenafil—Malaise—Thalidomide—leprosy	0.000312	0.00286	CcSEcCtD
Sildenafil—Vertigo—Thalidomide—leprosy	0.000311	0.00285	CcSEcCtD
Sildenafil—Syncope—Thalidomide—leprosy	0.000311	0.00285	CcSEcCtD
Sildenafil—Leukopenia—Thalidomide—leprosy	0.00031	0.00284	CcSEcCtD
Sildenafil—Palpitations—Thalidomide—leprosy	0.000306	0.00281	CcSEcCtD
Sildenafil—Loss of consciousness—Thalidomide—leprosy	0.000304	0.00279	CcSEcCtD
Sildenafil—Cough—Thalidomide—leprosy	0.000302	0.00277	CcSEcCtD
Sildenafil—Convulsion—Thalidomide—leprosy	0.0003	0.00275	CcSEcCtD
Sildenafil—Hypertension—Thalidomide—leprosy	0.000299	0.00274	CcSEcCtD
Sildenafil—Myalgia—Thalidomide—leprosy	0.000295	0.0027	CcSEcCtD
Sildenafil—Chest pain—Thalidomide—leprosy	0.000295	0.0027	CcSEcCtD
Sildenafil—Arthralgia—Thalidomide—leprosy	0.000295	0.0027	CcSEcCtD
Sildenafil—Anxiety—Thalidomide—leprosy	0.000294	0.00269	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000293	0.00269	CcSEcCtD
Sildenafil—Discomfort—Thalidomide—leprosy	0.000291	0.00267	CcSEcCtD
Sildenafil—Dry mouth—Thalidomide—leprosy	0.000288	0.00264	CcSEcCtD
Sildenafil—Oedema—Thalidomide—leprosy	0.000283	0.00259	CcSEcCtD
Sildenafil—Infection—Thalidomide—leprosy	0.000281	0.00257	CcSEcCtD
Sildenafil—Shock—Thalidomide—leprosy	0.000278	0.00255	CcSEcCtD
Sildenafil—Nervous system disorder—Thalidomide—leprosy	0.000277	0.00254	CcSEcCtD
Sildenafil—Tachycardia—Thalidomide—leprosy	0.000276	0.00253	CcSEcCtD
Sildenafil—Skin disorder—Thalidomide—leprosy	0.000275	0.00252	CcSEcCtD
Sildenafil—Hyperhidrosis—Thalidomide—leprosy	0.000273	0.00251	CcSEcCtD
Sildenafil—Anorexia—Thalidomide—leprosy	0.000269	0.00247	CcSEcCtD
Sildenafil—Hypotension—Thalidomide—leprosy	0.000264	0.00242	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Thalidomide—leprosy	0.000258	0.00236	CcSEcCtD
Sildenafil—Insomnia—Thalidomide—leprosy	0.000256	0.00234	CcSEcCtD
Sildenafil—Paraesthesia—Thalidomide—leprosy	0.000254	0.00233	CcSEcCtD
Sildenafil—Dyspnoea—Thalidomide—leprosy	0.000252	0.00231	CcSEcCtD
Sildenafil—Somnolence—Thalidomide—leprosy	0.000251	0.0023	CcSEcCtD
Sildenafil—Dyspepsia—Thalidomide—leprosy	0.000249	0.00228	CcSEcCtD
Sildenafil—Decreased appetite—Thalidomide—leprosy	0.000246	0.00225	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Thalidomide—leprosy	0.000244	0.00224	CcSEcCtD
Sildenafil—Fatigue—Thalidomide—leprosy	0.000244	0.00223	CcSEcCtD
Sildenafil—Constipation—Thalidomide—leprosy	0.000242	0.00222	CcSEcCtD
Sildenafil—Pain—Thalidomide—leprosy	0.000242	0.00222	CcSEcCtD
Sildenafil—CYP2E1—tendon—leprosy	0.000239	0.0105	CbGeAlD
Sildenafil—Feeling abnormal—Thalidomide—leprosy	0.000233	0.00214	CcSEcCtD
Sildenafil—Gastrointestinal pain—Thalidomide—leprosy	0.000231	0.00212	CcSEcCtD
Sildenafil—Urticaria—Thalidomide—leprosy	0.000225	0.00206	CcSEcCtD
Sildenafil—Abdominal pain—Thalidomide—leprosy	0.000223	0.00205	CcSEcCtD
Sildenafil—Body temperature increased—Thalidomide—leprosy	0.000223	0.00205	CcSEcCtD
Sildenafil—CYP1A1—nervous system—leprosy	0.000213	0.00939	CbGeAlD
Sildenafil—Hypersensitivity—Thalidomide—leprosy	0.000208	0.00191	CcSEcCtD
Sildenafil—Asthenia—Thalidomide—leprosy	0.000203	0.00186	CcSEcCtD
Sildenafil—Pruritus—Thalidomide—leprosy	0.0002	0.00183	CcSEcCtD
Sildenafil—CYP2E1—testis—leprosy	0.000198	0.00872	CbGeAlD
Sildenafil—CYP2E1—nervous system—leprosy	0.000194	0.00856	CbGeAlD
Sildenafil—Diarrhoea—Thalidomide—leprosy	0.000193	0.00177	CcSEcCtD
Sildenafil—Dizziness—Thalidomide—leprosy	0.000187	0.00171	CcSEcCtD
Sildenafil—Vomiting—Thalidomide—leprosy	0.00018	0.00165	CcSEcCtD
Sildenafil—Rash—Thalidomide—leprosy	0.000178	0.00163	CcSEcCtD
Sildenafil—Dermatitis—Thalidomide—leprosy	0.000178	0.00163	CcSEcCtD
Sildenafil—Headache—Thalidomide—leprosy	0.000177	0.00162	CcSEcCtD
Sildenafil—Nausea—Thalidomide—leprosy	0.000168	0.00154	CcSEcCtD
Sildenafil—CYP2D6—testis—leprosy	0.000157	0.00691	CbGeAlD
Sildenafil—CYP3A4—nervous system—leprosy	0.000156	0.00689	CbGeAlD
Sildenafil—CYP2D6—nervous system—leprosy	0.000154	0.00678	CbGeAlD
